Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
09/25/1996 | EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists |
09/25/1996 | EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments |
09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
09/25/1996 | EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3 |
09/25/1996 | EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery |
09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
09/25/1996 | CN1131666A Tricyclic pyrazole derivatives |
09/25/1996 | CN1131546A Vaginal antiphlogistic powder and its preparation method |
09/24/1996 | US5559153 Antiarrhythmia agents; cardiovascular disorders |
09/24/1996 | US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
09/24/1996 | CA2046533C Treatment of endometriosis |
09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
09/22/1996 | CA2172211A1 Treatment and prevention of prostatic cancer |
09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
09/19/1996 | WO1996028403A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION |
09/19/1996 | WO1996028175A1 Immunomodulating compositions from bile for the treatment of immune system disorders |
09/19/1996 | WO1996028155A1 Novel benzothiophene pharmaceutical compounds |
09/19/1996 | WO1996028154A2 Use of anti-oestrogens as male contraceptives |
09/19/1996 | WO1996028152A1 Novel benzofuran pharmaceutical compounds |
09/19/1996 | WO1996028146A1 Novel naphthyl pharmaceutical compounds |
09/19/1996 | WO1996028145A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility |
09/19/1996 | WO1996028142A1 Method and kit for preventing erectile dysfunction |
09/19/1996 | WO1996021463A3 New applications of lysozyme dimer |
09/19/1996 | DE19510862A1 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle Use of antiestrogens for male birth control |
09/19/1996 | CA2215373A1 Use of antiestrogens for male birth control |
09/19/1996 | CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction |
09/19/1996 | CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation |
09/19/1996 | CA2214450A1 Novel benzofuran pharmaceutical compounds |
09/19/1996 | CA2214416A1 Novel naphthyl pharmaceutical compounds |
09/19/1996 | CA2214261A1 Novel benzothiophene pharmaceutical compounds |
09/18/1996 | EP0732329A1 Chroman derivative |
09/18/1996 | EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals |
09/18/1996 | EP0731811A1 Chaperonin 10 |
09/18/1996 | EP0731790A1 Tachykinin antagonists |
09/18/1996 | EP0731789A1 Dp-iv-serine protease inhibitors |
09/18/1996 | EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
09/18/1996 | EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
09/18/1996 | CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
09/18/1996 | CN1131158A Steroids with 17-spiromethylene lactone or lactol group |
09/18/1996 | CN1131024A Traditional Chinese medicine preparation for curing tubal obstruction |
09/18/1996 | CN1032787C Synergistic treatment method |
09/17/1996 | US5556983 Phenylimidazolidines |
09/17/1996 | US5556981 Angiotensin II antagonist intermediates |
09/17/1996 | US5556845 11-β substituted-19-nor steroids |
09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
09/12/1996 | WO1996027658A1 Stimulation of meiosis |
09/12/1996 | WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity |
09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
09/12/1996 | WO1996027375A2 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
09/12/1996 | WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
09/12/1996 | WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
09/12/1996 | CA2214126A1 Stimulation of meiosis |
09/11/1996 | EP0731101A1 3-Benzyl-benzothiophenes |
09/11/1996 | EP0731100A1 Benzothiophene pharmaceutical compounds |
09/11/1996 | EP0731098A1 Alpha-substituted-3-benzyl-benzofurans |
09/11/1996 | EP0731097A1 Novel benzofuran pharmaceutical compounds |
09/11/1996 | EP0731093A1 Naphthyl pharmaceutical compounds |
09/11/1996 | EP0730657A1 Composition for the in vivo production of therapeutic products |
09/11/1996 | EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
09/11/1996 | EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
09/11/1996 | EP0730445A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors |
09/11/1996 | CN1130626A Adhesion receptor antagonists |
09/11/1996 | CA2171404A1 3-benzyl-benzothiophenes |
09/11/1996 | CA2171403A1 .alpha. substituted-1-benzyl-naphthyls |
09/11/1996 | CA2171399A1 Substituted-3-benzyl-benzofurans |
09/10/1996 | US5554642 Arylalkyl(thio) amides |
09/10/1996 | US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs |
09/10/1996 | US5554604 Method of controlling male fertility |
09/10/1996 | US5554600 Methods for inhibiting endometriosis |
09/10/1996 | US5554593 Therapeutic agent for threatened abortion |
09/06/1996 | WO1996026935A1 2-benzyl-3-arylbenzothiophenes |
09/06/1996 | WO1996026932A1 2-arylbenzazole compounds |
09/06/1996 | WO1996026727A1 Methods of inhibiting ovarian cancer |
09/06/1996 | WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases |
09/06/1996 | CA2214134A1 2-benzyl-3-arylbenzothiophenes |
09/06/1996 | CA2214080A1 Methods of inhibiting ovarian cancer |
09/04/1996 | EP0729964A1 Phosphorous-containing benzothiophenes |
09/04/1996 | EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods |
09/04/1996 | EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome |
09/04/1996 | EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods |
09/04/1996 | EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
09/04/1996 | EP0729755A2 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer |
09/04/1996 | EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists |
09/04/1996 | EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases |
09/04/1996 | CN1130063A Estogen effect promoting medicine |
09/03/1996 | US5552444 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes |
09/03/1996 | US5552417 Preventing premature sexual maturity, benzothiophene derivatives |
09/03/1996 | US5552416 Methods of inhibiting dysfunctional uterine bleeding |
09/03/1996 | US5552404 Compounds for neurotransmitters for animals |
09/03/1996 | US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
09/03/1996 | US5552401 2-benzyl-3-arylbenzothiophenes |
09/03/1996 | US5552150 Compostions containing di-linoleoyl-mono-gamma-linolenyl-glycerol |
08/29/1996 | WO1996026195A1 Benzothiazine dioxides as endothelin antagonists |
08/29/1996 | WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity |
08/29/1996 | CA2213192A1 Alpha.1a. adrenergic receptor antagonists |
08/29/1996 | CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity |
08/29/1996 | CA2211027A1 Benzothiazine dioxides as endothelin antagonists |
08/29/1996 | CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods |
08/29/1996 | CA2169414A1 Phosphorous-containing benzothiophenes |